Autolus Therapeutics plc

AUTL·NasdaqGS·Healthcare
Compare
1.7400−0.0700 (−3.87%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours1.8000+0.0600 (+3.45%)Oct 12, 5:57 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.8100
Open1.8000
Day range1.74001.8000
52-week range1.17502.5800
Off day high−3.33%
Off 52-week high−32.56%
Volume1.05M
Avg. volume (3M)2.09M
Market cap463.12M
EPS (TTM)-1.06
Forward P/E-2.78
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.14
Shares outstanding266.16M
Short interest4.87% of float
Earnings dateAug 11, 2026
Analyst target8.7250
Profit margin−238.65%

Against its peers

Compare in full ›
AUTL ALLO CABA FATE PGEN RNAC
Market cap 463.12M 483.69M 303.49M 255.22M 2.74B 211.48M
P/E (TTM) — — — — — —
Forward P/E -2.8 -2.3 -1.5 -2.2 -34.8 -1.8
Price/book 6.2 1.1 1.4 1.6 62.8 -1.7
Dividend yield — — — — — —
1-year change +7.41% +10.24% −22.49% +56.83% +143.30% −25.70%
Today −3.87% −4.11% −7.25% −2.29% −1.92% −0.92%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All AUTL news ›
markets.businessinsider.com·Positive

Autolus Therapeutics management to meet virtually with William Blair

Virtual Meeting to be held on September 24 hosted by William Blair. Published first on TheFly – the ultimate source for real-time, market-movin... Autolus Therapeutics management to meet virtually with William Blair Virtual Meeting to be…

markets.businessinsider.com·Positive

Autolus Therapeutics (AUTL) Receives a Buy from Wells Fargo

In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus Therapeutics, with a price target of $5.00. The company’... In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus…

markets.businessinsider.com·Positive

H.C. Wainwright Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Autolus Therapeutics, with a price target of $10.00. According to TipRanks, Bodnar is a 4-star analyst with an average return of 4.1% and a 37.75%…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.